peptide stability FAQ

Discard it. LL-37 loses 30–40% potency after 24 hours at room temperature due to methionine oxidation. The peptide may still appear clear and soluble, but antimicrobial activity against S. aureus and E. coli drops measurably within 12 hours at 20–25°C. The oxidised peptide cannot be restored. Refrigeration after room-temperature exposure does not reverse structural damage.

Lyophilized peptide can travel in carry-on luggage at ambient temperature for up to 48 hours. Pack it in its original sealed vial inside a protective case. Reconstituted peptide requires a medical-grade cooler (FRIO or equivalent) that maintains 2–8°C without ice. Standard TSA rules allow medically necessary cooling devices; bring documentation if asked. Never check reconstituted peptide in luggage. Cargo holds can reach 35°C+ on tarmacs, which destroys peptide activity within two hours.

Use it only for preliminary range-finding studies, not for data collection. Each freeze-thaw cycle reduces activity by an estimated 8–12% through ice crystal-induced structural damage. If your experimental design requires precise dose-response data or pharmacokinetic measurements, refrozen peptide introduces unquantified variability. Aliquot sizes should match single-session use volumes to eliminate refreeze temptation entirely.

Contact the supplier before reconstituting. Lyophilised TB-4 should appear as a fine white to off-white powder. Yellow discoloration suggests oxidative damage during lyophilisation or storage. Clumping indicates moisture exposure. The vial seal may have been compromised. Reconstituting degraded powder will not restore activity. Request a replacement batch and ask for a certificate of analysis with recent testing dates.

Discard it. A frozen reconstituted peptide solution has undergone ice crystal formation, which physically disrupts the peptide's tertiary structure. Even if you thaw it gently, a significant portion of the peptides will have aggregated into inactive forms. There's no way to reverse this damage, and using a degraded peptide introduces uncontrolled variables into your research. The cost of replacing the vial is far lower than the cost of compromised data.

Switch to a modified VIP analog or implement continuous infusion. Native VIP cannot sustain receptor activation beyond 8–12 minutes after a single dose due to rapid proteolytic clearance. Research groups have successfully used osmotic minipumps delivering VIP at 10–20 pmol/kg/min to maintain stable plasma concentrations over multi-hour experiments. Alternatively, stearyl-VIP or [Ala2,8,9,19]-VIP analogs provide 15–30 minute half-lives with reduced but still meaningful receptor affinity.

Use an insulated cooler with gel ice packs preconditioned to 2–8°C (not frozen solid. Frozen packs can drop the internal temperature below 0°C). Transport time should not exceed 6 hours. Include a calibrated temperature logger to verify the vial stayed within range. If temperature exceeded 15°C at any point, potency cannot be guaranteed. Repeat antimicrobial assays before using in experiments.

Discard it immediately. Cloudiness in previously clear peptide solution indicates either protein aggregation or microbial contamination. Both render the compound unusable. Aggregation occurs when peptides clump together into large, insoluble complexes that no longer interact with cellular targets. This can result from temperature cycling, pH shifts, or excessive agitation. Contamination-related cloudiness means bacterial or fungal growth has occurred despite the bacteriostatic water preservative, which happens when contamination levels exceed the preservative's inhibitory capacity. Neither condition is reversible, and administering aggregated or contaminated peptide poses safety risks. The proper response is disposal and reconstitution of a fresh vial using stricter sterile technique to prevent recurrence.

Use a validated cold-chain container that maintains 2–8°C for the entire transit duration. Standard insulin coolers or medical specimen transport bags with gel ice packs work for trips under six hours. Place the vial in the centre of the container surrounded by pre-chilled packs, and include a min-max thermometer to verify the temperature stayed within range. For longer transports, purpose-built peptide shipping containers with phase-change materials maintain stable cold temperatures for 24–48 hours. Never place the vial directly against ice packs. Direct contact can freeze portions of the solution. Wrap the vial in bubble wrap or foam to insulate it from temperature extremes while allowing passive cooling. If transporting across climates with ambient temperatures above 30°C, use active cooling systems rather than passive ice packs to prevent thermal overload.

Expect 25–40% loss of bioactivity. Each freeze-thaw cycle damages peptide integrity through ice crystal formation and osmotic stress. If your protocol has tight margins. Measuring subtle receptor activation or dose-response curves. The loss is too significant to ignore. For less sensitive applications, the remaining peptide may still produce measurable effects, but you cannot assume full potency. Aliquot reconstituted VIP into single-use volumes immediately to avoid this scenario.

If the peptides remained frozen (ice still present in the freezer) and power was restored within 12 hours, they're likely fine. Lyophilised peptides tolerate brief temperature increases better than reconstituted ones. If the freezer fully thawed (no ice, interior temperature above 10°C for multiple hours), assess on a peptide-by-peptide basis. Copper peptides (GHK-Cu) and BPC-157 are relatively stable and may retain 80–90% potency; shorter-chain peptides like Epithalon or Thymosin Beta-4 fragments degrade faster. When in doubt, contact the supplier. Some companies offer discounted replacements for documented storage failures.

Discard it. A reconstituted peptide solution left at room temperature (20–25°C) for 8+ hours has undergone significant degradation. The peptide backbone begins cleaving within 4–6 hours at ambient temperature, and bacterial contamination risk compounds every hour beyond that. Bacteriostatic water delays microbial growth but does not stop it; by morning, the solution is chemically compromised and potentially unsafe. The financial loss of one vial is negligible compared to the risk of injecting a degraded or contaminated solution.

You'll hit the 28-day stability ceiling before finishing the vial. The options are: (1) discard the remaining solution after 28 days and accept the waste, (2) adjust your protocol to use the peptide more frequently and finish it within the window, or (3) split the lyophilised powder into smaller vials before reconstitution using aseptic technique in a sterile environment. The third option requires advanced lab skills and increases contamination risk, so most researchers default to option (1) and reconstitute smaller vials more frequently. Our team's consistent recommendation is to order smaller vial sizes matched to your actual usage timeline rather than attempting to extend the post-reconstitution window.

Use a validated cold shipper with an internal temperature logger, not a standard cooler with gel packs. Gel packs maintain 2–8°C for 24–36 hours under ideal conditions, but real-world transit introduces delays and thermal stress. If transport exceeds 4 hours, freeze the aliquot at −80°C before shipping and thaw it in a 2–8°C refrigerator upon arrival. Never thaw at room temperature or in a water bath. Rapid temperature changes promote aggregation.

This is suboptimal but manageable if fluctuations are brief. Prolonged exposure above 8°C accelerates degradation, but short spikes during door openings or defrost cycles are unlikely to destroy potency within the 28-day window. To minimize risk, store the vial on a middle shelf away from the door, where temperature is most stable. If your refrigerator consistently exceeds 8°C, consider using a dedicated laboratory refrigerator or a portable medication cooler.

If the lyophilized powder remained frozen (ice crystals still present when you check it), it's likely still viable. But stability is compromised. Use it within 6 months rather than the standard 12–24-month window. If the vial thawed completely, condensation inside the container has already begun hydrolysis. Reconstitute and use it immediately rather than refreezing.

Check the duration and whether the vials thawed. Lyophilised peptides tolerate brief temperature increases better than reconstituted solutions. If the power outage lasted under 12 hours and the freezer remained closed, the internal temperature likely stayed below 0°C and the peptides are salvageable. If the outage exceeded 24 hours or the vials reached room temperature, potency degrades but doesn't immediately vanish. Peptides that underwent one freeze-thaw cycle in lyophilised form retain approximately 85–90% of original activity if refrozen promptly. Multiple cycles compound the loss. Three cycles typically reduce potency by 30–40%. If you're uncertain about temperature history, reconstitute a small test vial and observe for cloudiness or precipitation, which signals aggregation. For critical research applications, discard and reorder rather than risk inconsistent results from thermally stressed material.

Check the vial temperature when power is restored. If the lyophilised peptide remained below 0°C (still frozen solid), it's likely stable. Peptide degradation below freezing is negligible over short timelines. If the vial thawed completely (reached 10–15°C), treat it as compromised. A single thaw event doesn't destroy the peptide, but you've used one of your maximum three freeze-thaw cycles. Mark the vial and prioritise it for near-term reconstitution rather than extended storage.

Discard it. A single 8–12 hour ambient temperature exposure at 20–25°C causes 10–15% activity loss. Enough to introduce uncontrolled variability into your dataset. The peptide may appear clear and unchanged, but methionine oxidation and low-level aggregation have already begun. Running compromised TB-4 through an experimental protocol wastes animal models, reagents, and weeks of work. The cost of replacing one vial is negligible compared to the cost of invalid data.

Use a validated cold-chain container. Medical specimen transport bags with gel packs rated for 2–8°C work well for trips under 6 hours. For longer transport, use an active cooling system (a portable refrigerator or a phase-change material designed for biologics transport). Never rely on standard ice packs. They're often too cold and can freeze the vial. Store ara-290 long term by maintaining the 2–8°C range continuously, even during transport.